From Wikipedia, the free encyclopedia
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is a medium sized multinational pharmaceutical company based in Hyderabad, India. The company was founded by Dr Anji Reddy in 1984. Dr Reddy's main business is manufacturing and marketing generic drugs, though it is also researching some new drugs. These are initially sold in India and other developing nations; once the original patents expire, they are also imported into the U.S., Europe, and other industrialized nations.
Dr. Reddy's is presently licensed by Merck & Co. to sell an authorized generic version of the popular drug simvastatin (Zocor) in the U.S. Since Dr. Reddy's has a license from Merck, it is not subject to the exclusivity period on generic simvastatin of 180 days from June 23, 2006, which is split between Ranbaxy Laboratories (also from India) and Teva Pharmaceutical Industries.
[edit] Key people as on March 31, 2006
- Dr. K Anji Reddy - chairman
- Mr. G V Prasad - vice chairman & CEO
- Mr. Satish Reddy - managing director & COO
- Mr. Anupam Puri - independent director
- Dr. Krishna G Palepu - independent director
- Dr. Omkar Goswami - independent director
- Mr. P N Devarajan - independent director
- Mr. Ravi Bhoothalingam - independent director
- Dr. V Mohan - independent director
[edit] Key products
[edit] Top-15 active pharmaceutical ingredients
[edit] Top-10 brands in India
- Nise
- Omez
- Stalmo
- Stalmo Beta
- Enam
- Atocor
- Razo
- Reclimet
- Clamp
- Mintop
[edit] External links
This Indian corporation, company, Cooperative, NGO or Public Sector Undertaking article is a stub. See the WikiProject India for article coordination. You can help Wikipedia by expanding it.
